Icon

OFORTA (nda022273)- (10MG)

FLUDARABINE PHOSPHATE SANOFI AVENTIS US
10MG
No No
2022-Dec-20 Expired
2015-Dec-18 None
None No
Oforta™ (fludarabine phosphate tablets) is a nucleotide metabolic inhibitor indicated as a single agent for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) whose disease has not responded to or has progressed during or after treatment with at least one standard alkylating-agent containing regimen.
0 0 0
Total Other Developers None
Drugs with Suitability No
10MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.